Mekonos Inc.

We’re enroute to Baltimore, MD for the American Society of Gene & Cell Therapy’s Annual Meeting where we’ll be presenting a poster on Silicon Nanoneedle Microarray-Based Delivery of Cell Gene Therapies. Interested in hearing more about how Mekonos’ technology unlocks hyper precise ex vivo single cell engineering at scale? Be sure to stop by the Nonviral Therapeutic Gene Delivery and Synthetic/Molecular Conjugates poster session on Thursday to say hi to our team. Or get in touch at: mekonos.com/contact #ASGCT2024 #CellandGeneTherapy #SystemonaChip 

We’re excited to announce that we’re partnering with ACCELERATED BIOSCIENCES CORP. to codevelop a powerful, new manufacturing cell line based on their human Trophoblast Stem Cells (hTSCs) and Gene Engineered Multi-Sites (GEMS) technology! With early access to Mekonos’ technology, Accelerated Bio will be able to bypass the limitations of conventional delivery approaches like electroporation, for improved non-viral delivery into its fragile stem cells. We look forward to working closely with their team to enable the development of a next-generation cell line for biomanufacturing from their unique stem cell source. Read more here: https://lnkd.in/g7dFp9XW #stemcells #biomanufacturing #cellandgenetherapy

We hope you will join Jake Lesnik next week at SynBioBeta 2024 for an in-depth panel discussion on “Advancing Drug Discovery & Screening” that will explore the latest strategies and technologies revolutionizing drug discovery and screening processes. Can synbio therapeutics redefine the future of medicine? This is a great opportunity to learn more about Mekonos’ scalable platform which offers the delivery of any molecular cargo to any cell, supporting cell and gene therapy programs from the R&D stage through the manufacturing process. See you in San Jose! Interested in setting up a meeting? Get in touch at mekonos.com/contact #SynBioBeta2024 #DrugDiscovery #PharmaInnovation

We’re looking forward to showcasing how Mekonos’ novel technology can be utilized for next gen genetic engineering of myeloid cells at the Keystone Symposia on Molecular & Cellular Biology’s Myeloid Targeting Strategies for Cancer Treatment in Killarney, Ireland next week! Attending and want to connect? Get in touch at: mekonos.com/contact #KSMyeloidTargets24 #InnateImmunity #CancerImmunotherapy #CellandGeneTherapy

Attending SynBioBeta 2024? We hope you will join us on Thurs., May 9th from 4:45 to 5:15 pm for a captivating panel discussion titled "Gene Meets Cell: The SynBio Evolution in Targeted Therapeutics." Our CEO, Anil Narasimha, will join esteemed panelists Avencia Sanchez-Mejias PhD from Integra Therapeutics and Daniel Georgiev from Sampling Human to discuss the latest advancements in gene technology for therapeutic use and the potential impact that new approaches will have on the healthcare field. Join us for an insightful discussion and learn how Mekonos is leading the charge in this exciting field. See you there! Not attending but want to learn more? Get in touch at mekonos.com/contact #SynBioBeta2024 #GeneTherapy #CellTherapy #SyntheticBiology

Today is National DNA Day – a time to celebrate the completion of the human genome project and to mobilize, energize and empower members of the STEM community to innovate, collaborate and discover the promise of our shared humanity and connection to the natural world.   The potential of our platform technology would not be possible without the dedicated efforts of the countless scientists before us in genomic research. In their honor, we’re excited to share a preview of how our technology is redefining high efficiency, high viability cell engineering like we’ve never seen before.   #NationalDNADay #CellandGeneTherapy #SystemOnaChip

Curious to learn how our scalable platform offers the delivery of any molecular cargo to any cell, supporting cell and gene therapy programs from the R&D stage through the manufacturing process?   Check out this video showing how we combine three core technologies to offer the first non-viral delivery platform which enables single-cell precision at scale - and be sure to tune into Anil Narasimha’s company presentation tomorrow at 9:30am (GMT+2) during the Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Med.    #CGMed24 #CellandGeneTherapy #Innovation  

Did you know that Roman-style pizza, also known as pizza al taglio, was originally crafted in the early 1900s as a quick and convenient snack for workers on their lunch breaks in Rome, Italy?   In the spirit of celebrating the hardworking cell and gene therapy community at #CGMed24, we sponsored a pizza feast last night to help fuel everyone for a productive few days of panel discussions, company presentations, workshops and partnering meetings.   A big thank you to all who joined us!   #PizzaLove #CellandGeneTherapy

Our team is headed to Rome, Italy for the 2024 Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Med!   We hope you will join Anil Narasimha’s company presentation on Thurs., April 11 at 9:30am (GMT+2) to learn more about how Mekonos’ cutting-edge platform combines three powerful technologies to unlock new abilities in engineering cells, so that new types of cell and gene therapies — ones that can only be dreamed of today — soon become a reality.   Attending? We welcome the opportunity to sit down for lunch or coffee to get to know you and your organization. Get in touch via the conference partnering tool!   #CGMed24 #CellandGeneTherapy #CGT

Mekonos envisions a future where personalized medicine is accessible to all. Our technology can turn the body’s own cells into therapies that may one day cure a variety of hard-to-treat diseases. As the saying goes, extraordinary belongs to those that create it, and we are so proud of each and every member of our team who is resolved to help us realize this vision. Congrats to our operations colleagues, Thomas Masterson, Tammy Mellon and Nupur S. on their recent role changes. Together on this journey we will support better health, one cell at a time! #teamgrowth #companyculture #cellandgenetherapy